It is only recently that other functions for GLP-1, for example in the brain and cardiovascular system, have also been recognized 12,13
[51] The developing endocrine system may be particularly sensitive to exogenous melatonin, and long-term safety data in pediatric populations remain limited
For Intramuscular Use Only: Disclaimer: This product description was generated by AI and is intended for informational purposes only
Geybels were employees and shareholders of Novo Nordisk at the time of the analysis
Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss